Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses

NCT05129072•Bausch & Lomb Incorporated

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Contact Lens Wearer

Interventions

kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D

Locations

United States

Locations (1)

Bausch and Lomb Site 01

Rochester, New York, United States

Key Dates

Start Date

August 25, 2021

Primary Completion Date

September 24, 2021

Completion Date

September 24, 2021

Last Updated

June 24, 2025

Sponsors

Lead Sponsor

Bausch & Lomb Incorporated

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions